【レポートの概要（一部）】
Table of Contents
Chapter 1. Executive Summary
1.1. Pharmacovigilance– Industry Summary and Critical Success Factors (CSFs)
Chapter 2. Pharmacovigilance Industry Outlook
2.1. Market Segmentation
2.2. Market Size and Growth Prospects
2.3. Pharmacovigilance – Market dynamics
2.3.1. Market Driver Analysis
2.3.2. Market Restraint Analysis
2.4. Key Opportunities Prioritized
2.5. Pharmacovigilance – PESTEL Analysis
2.6. Pharmacovigilance Company Market Share Analysis, 2013
Chapter 3. Pharmacovigilance Clinical Trial Phase Outlook
3.1. Pharmacovigilance market share, by clinical trial phase, 2013 & 2020
3.2. Preclinical
3.2.1. Preclinical Market Estimates and Forecasts, 2012 – 2020 (USD Million)
3.3. Phase 0
3.3.1. Phase 0 Market Estimates and Forecasts, 2012 – 2020 (USD Million)
3.4. Phase I
3.4.1. Phase I Market Estimates and Forecasts, 2012 – 2020 (USD Million)
3.5. Phase II
3.5.1. Phase II Market Estimates and Forecasts, 2012 – 2020 (USD Million)
3.6. Phase III
3.6.1. Phase III Market Estimates and Forecasts, 2012 – 2020 (USD Million)
3.7. Phase IV
3.7.1. Phase IV Market Estimates and Forecasts, 2012 – 2020 (USD Million)
Chapter 4. Pharmacovigilance Type of Service Provider Outlook
4.1. Pharmacovigilance market share, by type of service provider, 2013 & 2020
4.2. In- House
4.2.1. In-House Market Estimates and Forecasts, 2012 – 2020 (USD Million)
4.3. Contract Outsourcing
4.3.1. Contract Outsourcing Market Estimates and Forecasts, 2012 – 2020 (USD Million)
Chapter 5. Pharmacovigilance Regional Outlook
5.1. Pharmacovigilance market share by region, 2012 & 2020
5.2. North America
5.2.1. Market Estimates and Forecasts, by Clinical Trial Phase
5.2.2. Market Estimates and Forecasts, by Type of Service Provider
5.3. Europe
5.3.1. Market Estimates and Forecasts, by Clinical Trial Phase
5.3.2. Market Estimates and Forecasts, by Type of Service Provider
5.4. Asia Pacific
5.4.1. Market Estimates and Forecasts, by Clinical Trial Phase
5.4.2. Market Estimates and Forecasts, by Type of Service Provider
5.5. RoW
5.5.1. Market Estimates and Forecasts, by Clinical Trial Phase
5.5.2. Market Estimates and Forecasts, by Type of Service Provider
Chapter 6. Competitive Landscape
6.1 Accenture Plc.
6.1.1 Company Overview
6.1.2 Financial Performance
6.1.3 Product Benchmarking
6.1.4 Strategic Initiatives
6.2 Boehringer Ingelheim GmbH
6.2.1 Company Overview
6.2.2 Financial Performance
6.2.3 Product Benchmarking
6.2.4 Strategic Initiatives
6.3 Bristol-Myers Squibb
6.3.1 Company Overview
6.3.2 Financial Performance
6.3.3 Product Benchmarking
6.3.4 Strategic Initiatives
6.4 Clinquest Group B.V.
6.4.1 Company Overview
6.4.2 Financial Performance
6.4.3 Product Benchmarking
6.4.4 Strategic Initiatives
6.5 Cognizant Technology Solutions Corporation
6.5.1 Company Overview
6.5.2 Financial Performance
6.5.3 Product Benchmarking
6.5.4 Strategic Initiatives
6.6 Covance, Inc.
6.6.1 Company Overview
6.6.2 Financial Performance
6.6.3 Product Benchmarking
6.6.4 Strategic Initiatives
6.7 F. Hoffmann-La Roche Ltd
6.7.1 Company Overview
6.7.2 Financial Performance
6.7.3 Product Benchmarking
6.7.4 Strategic Initiatives
6.8 GlaxoSmithKline (GSK)
6.8.1 Company Overview
6.8.2 Financial Performance
6.8.3 Product Benchmarking
6.8.4 Strategic Initiatives
6.9 IBM Corporation
6.9.1 Company Overview
6.9.2 Financial Performance
6.9.3 Product Benchmarking
6.9.4 Strategic Initiatives
6.10 ICON, Plc
6.10.1 Company Overview
6.10.2 Financial Performance
6.10.3 Product Benchmarking
6.10.4 Strategic Initiatives
6.11 iGATE Corporation
6.11.1 Company Overview
6.11.2 Financial Performance
6.11.3 Product Benchmarking
6.11.4 Strategic Initiatives
6.12 iMEDGlobal Corporation
6.12.1 Company Overview
6.12.2 Financial Performance
6.12.3 Product Benchmarking
6.12.4 Strategic Initiatives
6.13 Infosys
6.13.1 Company Overview
6.13.2 Financial Performance
6.13.3 Product Benchmarking
6.13.4 Strategic Initiatives
6.14 Ipca Laboratories Ltd
6.14.1 Company Overview
6.14.2 Financial Performance
6.14.3 Product Benchmarking
6.14.4 Strategic Initiatives
6.15 Janssen Research & Development, LLC
6.15.1 Company Overview
6.15.2 Financial Performance
6.15.3 Product Benchmarking
6.15.4 Strategic Initiatives
6.16 Novartis International AG
6.16.1 Company Overview
6.16.2 Financial Performance
6.16.3 Product Benchmarking
6.16.4 Strategic Initiatives
6.17 PAREXEL International Corporation
6.17.1 Company Overview
6.17.2 Financial Performance
6.17.3 Product Benchmarking
6.17.4 Strategic Initiatives
6.18 Pfizer, Inc.
6.18.1 Company Overview
6.18.2 Financial Performance
6.18.3 Product Benchmarking
6.18.4 Strategic Initiatives
6.19 Pharmaceutical Product Development, Inc. (PPD, Inc.)
6.19.1 Company Overview
6.19.2 Financial Performance
6.19.3 Product Benchmarking
6.19.4 Strategic Initiatives
6.20 Sanofi Aventis
6.20.1 Company Overview
6.20.2 Financial Performance
6.20.3 Product Benchmarking
6.20.4 Strategic Initiatives
6.21 Synowlwedge LLC
6.21.1 Company Overview
6.21.2 Financial Performance
6.21.3 Product Benchmarking
6.21.4 Strategic Initiatives
6.22 Wipro Ltd.
6.22.1 Company Overview
6.22.2 Financial Performance
6.22.3 Product Benchmarking
6.22.4 Strategic Initiatives
6.23 PRA Health Sciences Inc.
6.23.1 Company Overview
6.23.2 Financial Performance
6.23.3 Product Benchmarking
6.23.4 Strategic Initiatives
6.24 Quantum Solutions India
6.24.1 Company Overview
6.24.2 Financial Performance
6.24.3 Product Benchmarking
6.24.4 Strategic Initiatives
6.25 Quintiles Transnational Corporation
6.25.1 Company Overview
6.25.2 Financial Performance
6.25.3 Product Benchmarking
6.25.4 Strategic Initiatives
6.26 inVentiv Health Inc.
6.26.1 Company Overview
6.26.2 Financial Performance
6.26.3 Product Benchmarking
6.26.4 Strategic Initiatives
6.27 OptumInsight, Inc.
6.27.1 Company Overview
6.27.2 Financial Performance
6.27.3 Product Benchmarking
6.27.4 Strategic Initiatives
6.28 United BioSource Corporation
6.28.1 Company Overview
6.28.2 Financial Performance
6.28.3 Product Benchmarking
6.28.4 Strategic Initiatives
6.29 Ecron Acunova
6.29.1 Company Overview
6.29.2 Financial Performance
6.29.3 Product Benchmarking
6.29.4 Strategic Initiatives
6.30 Fortitude Clinical
6.30.1 Company Overview
6.30.2 Financial Performance
6.30.3 Product Benchmarking
6.30.4 Strategic Initiatives
6.31 ITClinical
6.31.1 Company Overview
6.31.2 Financial Performance
6.31.3 Product Benchmarking
6.31.4 Strategic Initiatives
Chapter 7. Methodology and Scope
7.1. Research Methodology
7.2. Research Scope & Assumption
7.3. List of Data Sources
List of Tables
1. Pharmacovigilance Market – Industry Summary & Critical Success Factors (CSFs)
2. Global Pharmacovigilance Market Revenue, By Clinical Trial Phase, 2012 – 2020, Revenue (USD Million)
3. Global Pharmacovigilance Market Revenue, By Type of Service Provider , 2012 – 2020, Revenue (USD Million)
4. Global Pharmacovigilance Market Revenue, By Region, 2012 – 2020, Revenue (USD Million)
5. Pharmacovigilance Market – Key market driver analysis
6. Pharmacovigilance – Key market restraint analysis
7. North America Pharmacovigilance Market Size And Trends, 2012 – 2020, Revenue (USD Million)
8. North America Pharmacovigilance Market Revenue, By Clinical Trial Phase, 2012 – 2020 (USD Million)
9. North America Pharmacovigilance Market Revenue, By Type of Service provider, 2012 – 2020 (USD Million)
10. Europe Pharmacovigilance Market Size And Trends, 2012 – 2020, Revenue (USD Million)
11. Europe Pharmacovigilance Market Revenue, By Clinical Trial Phase, 2012 – 2020 (USD Million)
12. Europe Pharmacovigilance Market Revenue, By Type of service Provider, 2012 – 2020 (USD Million)
13. Asia Pacific Pharmacovigilance Market Size And Trends, 2012 – 2020, Revenue (USD Million)
14. Asia Pacific Pharmacovigilance Market Revenue, By Clinical Trial Phase, 2012 – 2020 (USD Million)
15. Asia Pacific Pharmacovigilance Market Revenue, By Type of service Provider, 2012 – 2020 (USD Million)
16. RoW Pharmacovigilance Market Size And Trends, 2012 – 2020, Revenue (USD Million)
17. RoW Pharmacovigilance Market Revenue, By Clinical Trial Phase, 2012 – 2020 (USD Million)
18. RoW Pharmacovigilance Market Revenue, By Type of Service Provider, 2012 – 2020 (USD Million)
List of Figures
1. Pharmacovigilance: Market Segmentation
2. Global Pharmacovigilance Market, 2012 – 2020, Revenue (USD Million)
3. Pharmacovigilance Market Dynamics
4. Key Opportunities Prioritized
5. Pharmacovigilance Market – Porter’s Analysis
6. Pharmacovigilance Market – PESTEL Analysis
7. Pharmacovigilance Company Market Share Analysis, 2013
8. Pharmacovigilance Market Share, By Clinical Trial Phase, 2013 & 2020
9. Pharmacovigilance Market Share, By Type of Service Provider, 2013 & 2020
10. Pharmacovigilance Market Share, By Region, 2013 & 2020
【レポート販売概要】
■ タイトル：医薬品の副作用調査の世界市場分析：臨床試験フェーズ別（前臨床試験、フェーズI / 1、フェーズII / 2、フェーズIII / 3、フェーズIV / 4試験）、サービス提供者別（自宅内、契約委託）、セグメント予測、-2020■ 英文：Pharmacovigilance Market Analysis By Clinical Trial Phases (Preclinical Studies, Phase I/1, Phase II/2, Phase III/3, Phase IV/4 Trial), By Type Of Service Providers (In House, Contract Outsourcing) And Segment Forecasts To 2020
■ 発行日：2015年2月15日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW707656
■ 調査対象地域：グローバル
- 金属製キャップ・クロージャの世界市場2016-2020About Caps and Closures Caps and closures provide protection from the external environment and tamper resistance for food and beverages products, pharmaceutical products, and other consumer and industrial goods. Caps and closures aid in the reliable distribution of products in the value chain by providing protection to the product from spilling or getting contaminated. The different types of mater …
- 発熱物質（パイロジェン）試験の世界市場：装置、サービス、キット、試薬The global pyrogen testing market is valued at USD 610.2 Million in 2016 and is expected to grow at a CAGR of 12.2%, to reach USD 1086.3 Million by 2021. Pyrogen testing is important and mandatory step in the manufacturing process to remove or inactivate potential bacterial toxins. Pyrogen testing product are used for the treatment and diagnostic purposes in humans. As the disease burden in the wo …
- アルコール性肝炎(Alcoholic Hepatitis)：治療薬開発パイプライン動向（2015年上半期版）Alcoholic Hepatitis - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Alcoholic Hepatitis - Pipeline Review, H1 2015’, provides an overview of the Alcoholic Hepatitis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Alcoholic Hepatitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, m …
- 世界のTV及びビデオサービス市場データベース：地上波テレビ、ケーブルテレビ、IPTV、OTTビデオサービス等n/a
- 世界における消化促進食品・飲料市場動向（2014-2018）About Digestive Health Food and Drinks Digestive health food and drinks are products that are primarily designed to ease the symptoms of an overburdened digestive tract. Digestive health food and drink products also help in the prevention of many digestive health disorders such as gastroesophageal reflux disease, peptic ulcer disease, irritable bowel disease, ulcerative colitis, and Crohn's diseas …
- 呼吸保護装置（RPE）の世界市場：濾過式呼吸用保護具（APR）、自給式呼吸器（SCBA）About RPE RPE is used to minimize the wearers’ exposure to airborne hazards. RPE finds application in industries such as manufacturing, chemicals, construction, oil and gas, food, and pharmaceuticals. RPE is used not only by industrial consumers but also by the general public to protect from pollution. The selection of RPE depends on risks that the wearer is exposed to and the intensity and durati …
- 電子式商品監視（EAS）の世界市場予測（～2024年）“Electronic article surveillance market to grow at CAGR of 3.6% from 2019 to 2024.” The electronic article surveillance (EAS) market is expected to grow from USD 981 million in 2019 to USD 1,173 billion by 2024, at a CAGR of 3.6%. Protection against inventory losses, shoplifting, and theft and modernizing retail sector are the major driving factors for the market growth during the forecast period. …
- ゼオライトの世界市場：製品別（天然、人工）、用途別（触媒、洗剤ビルダー）、地域別予測Global Zeolite Market to reach USD XXX billion by 2025. Global Zeolite Market valued approximately USD XXX billion in 2016 is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2017-2025. Key factors success factors of growing demand for detergents, rising hygiene awareness among consumers, and rising refining output. Furthermore, escalating need for natural p …
- 電子パッケージングの世界市場：RFID、電子式商品監視（EAS）About Electronic Packaging Electronic packaging involves the use of engineering and other technologies to incorporate in-built security and protective features in the packaging of products. The use of electronics in packaging is gaining importance as it reduces wastage and enhances safety and security, product differentiation, convenience, brand enhancement, and quality assurance. Printed electron …
- パッケージ化された廃水処理設備の世界市場2016-2020About Packaged Wastewater Treatment Packaged wastewater treatment plants are pre-engineered and custom designed treatment facilities used to treat wastewater for small communities, municipalities, and industries. These plants are typically constructed in a factory and simply transported to and installed at the site of requirement. They are designed to treat 0.002- 5 MGD water, depending on the req …
- 世界の艦艇/水上戦闘艦艇市場：競争状況及び戦略的インサイトSummary This report shows the leading Naval Vessels and Surface Combatants market segments in various regions across the world. Details of top companies active across the global Naval Vessels and Surface Combatants market are provided, together with market size and forecast 2013-2023 for the main players across those areas. Key Findings The report provides a detailed analysis of the competitive la …
- 多関節ロボットの世界市場予測（～2023年）The articulated robot market (excluding the cost of robotic peripherals, software, and system engineering) is expected to grow from USD 10.92 Billion in 2018 to USD 23.51 Billion by 2023, at a CAGR of 16.58% during the forecast period. The articulated robot market is expected to register a shipment of 245,012 units in 2018 and is expected to reach 548,566 units by 2023, at a CAGR of 17.49% during …
- 飼料用微量ミネラルの世界市場：有機微量ミネラル、無機微量ミネラルAbout Trace Minerals for Animal Feed Trace minerals are micronutrients that are used in small quantities in animal feed. Though only small quantities of organic trace minerals are added to animal feed, they play an important role in maintaining animal health. Trace minerals used in animal feed can be organic or inorganic in nature. The bioavailability of organic trace minerals is higher than that …
- 板金装置の世界市場：金属切削装置、金属成形装置、溶接装置About Sheet Metals Sheet metals are created with the help of an industrial process that turns metals, such as brass, copper aluminum, steel, titanium, tin, and nickel, into thin and flat pieces. Sheet metals are one of the basic metal forms used in the metal fabrication industry. Technavio’s analysts forecast the global sheet metal equipment market to grow at a CAGR of 6.69% during the period 2016 …
- 世界の臨床化学及び免疫診断市場This 320-page report presents an overview of the clinical significance and market needs for major Chemistry, TDM, Endocrine, Cancer, Immunoprotein, and Abused Drug assays, including listings of companies developing or marketing new technologies and products.The report also presents strategic assessments of current and emerging suppliers of clinical chemistry and immunodiagnostic products, includin …
